July 24, 2014 2:51 AM ET

Company Overview of Moffitt Cancer Center

Company Overview

Moffitt Cancer Center is based in the United States.

,  

United States

Key Executives for Moffitt Cancer Center

Chief Operating Officer
Chief Nursing Officer and Vice President
Chief Health Information Officer and Vice President
Compensation as of Fiscal Year 2014.

Moffitt Cancer Center Key Developments

Rosetta and Moffitt Enter into Agreement to Develop Thyroid Neoplasia Assay

Rosetta Genomics Ltd. and Moffitt Cancer Center have entered into an agreement for the development and commercialization of Rosetta's thyroid neoplasia assay. Under the agreement, Rosetta will work with Marino Leon, associate member of the Department of Anatomic Pathology at Moffitt. A fine needle aspiration (FNA), a non-surgical procedure used to obtain tissue for analysis by a pathologist, is the standard technique for detecting cancer.

Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Cente and Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Form Cancer Research Collaboration for Big Data

Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Cente and Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), announced a collaboration to accelerate discoveries in cancer research. Named the Oncology Research Information Exchange Network (ORIEN), the new partnership will launch with over 100,000 consented patients who have agreed to donate their tissue and clinical data for research to understand cancer at the molecular level. ORIEN will utilize a single protocol, Total Cancer Care(R), to create a collaborative, "rapid learning" environment that will share de-identified data to accelerate the development of targeted treatments, allowing researchers and clinicians to more quickly match eligible patients to clinical trials and conduct larger and richer analysis. Through data analysis and sharing, ORIEN will provide physicians evidence of the best therapeutic options, including clinical trial treatments, specific to a patient's biological and epidemiological profile, increasing the likelihood of treatment efficacy, speeding response time, and potentially minimizing side effects while improving outcomes. ORIEN builds upon the strengths of its founders' National Cancer Institute-designated comprehensive cancer centers: Moffitt's Total Cancer Care protocol, biorepository and data warehouse of patients' genotypic and phenotypic data, and OSUCCC-James's depth and breadth in translating molecular- and genetic-based discoveries into more effective ways to prevent, detect, treat and ultimately cure cancers. M2Gen(R), a subsidiary of Moffitt, will serve as ORIEN's operational and commercial provider for support, bringing expertise in data management and informatics.

Moffitt Cancer Center Presents at The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum, Mar-19-2014 08:30 AM

Moffitt Cancer Center Presents at The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum, Mar-19-2014 08:30 AM. Venue: New York Academy of Sciences, New York, United States. Speakers: James Mule, Associate Center Director.

Similar Private Companies By Industry

Company Name Region
Circle Entertainment SV-I, LLC United States
Hartman's Plants Laboratories Inc. United States
Prince Street Latin America Ltd. United States
Merchant-Mark VI Boston LLC United States
Image Printing Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Moffitt Cancer Center, please visit www.moffittcancercenter.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.